Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosis

Katarina Tešija, Mašan Sredanović, Laura Zanetti, Tereza Gabelić, Ivan Adamec, Barbara Barun, Magdalena Krbot Skorić, Mario Habek

Open source

DOI: 10.1016/j.msard.2026.107373
Published: 2026-09
Container: Multiple Sclerosis and Related Disorders
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2026.107373,
  title = {Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosis},
  author = {Katarina Tešija and Mašan Sredanović and Laura Zanetti and Tereza Gabelić and Ivan Adamec and Barbara Barun and Magdalena Krbot Skorić and Mario Habek},
  year = {2026},
  journal = {Multiple Sclerosis and Related Disorders},
  doi = {10.1016/j.msard.2026.107373},
  url = {https://doi.org/10.1016/j.msard.2026.107373}
}

RIS

TY  - JOUR
TI  - Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosis
AU  - Katarina Tešija
AU  - Mašan Sredanović
AU  - Laura Zanetti
AU  - Tereza Gabelić
AU  - Ivan Adamec
AU  - Barbara Barun
AU  - Magdalena Krbot Skorić
AU  - Mario Habek
PY  - 2026
JO  - Multiple Sclerosis and Related Disorders
DO  - 10.1016/j.msard.2026.107373
UR  - https://doi.org/10.1016/j.msard.2026.107373
ER  -

APA

Tešija, K., Sredanović, M., Zanetti, L., Gabelić, T., Adamec, I., Barun, B., Skorić, M. K., & Habek, M. (2026). Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosis. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2026.107373

Source records

crossref · retrieved 2026-09-25T10:10:17.976Z